Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device
Conclusions: Patients who had GI bleeding were at significantly higher risk for a subsequent TE event. Although the exact cause of this relationship is unknown, it suggests that a reduction in anti-coagulation and anti-platelet management to treat GI bleeds may contribute to this risk.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: John M. Stulak, Dustin Lee, Jonathon W. Haft, Matthew A. Romano, Jennifer A. Cowger, Soon J. Park, Keith D. Aaronson, Francis D. Pagani Tags: Featured Articles Source Type: research
More News: Bleeding | Cardiology | Coumadin | Gastroenterology | Heart | Heart Transplant | Ischemic Stroke | Lung Transplant | Stroke | Thrombosis | Transplant Surgery | Transplants | Warfarin